ABSTRACT To clarify the metabolic fate of radioiodinated heptadecanoic acid in myocardium, the time course and distribution of the radioactivity over '311-heptadecanoic acid, free radioiodide, and various lipids (with incorporated iodoheptadecanoic acid) were determined in normal canine myocardium. In 10 dogs seven biopsy specimens were taken over 30 min after injection of 1311-heptadecanoic acid. The radioactivity in the specimens increased until the fifth minute and decreased thereafter, with a half-time of 36 min. In the fifth minute, 61% of the radioactiviy was free iodide, and its curve paralleled the curve of the total radioactivity. As early as the first minute 13'I-heptadecanoic acid activity was reduced to 14% and decreased further. Activity of radioiodinated phospholipids, (mono, di, tri)-glycerides, and cholesterol-esters remained constant after an initial increase. These results indicate that immediately after uptake, '3'I-heptadecanoic acid is either metabolized, liberating the radioiodide, or stored in lipids. Because the activity of radiolabeled lipids remained constant during the study period and because iodide activity paralleled the total activity in biopsy specimens, it is concluded that in normal myocardium, washout of free radioiodide determines the elimination rate as observed during a scintigraphic study. Thus the elimination rate cannot be related to the ,8-oxidation rate as previously supposed. Circulation 72, No. 3, 565-71, 1985. THE HEART uses a variety of substances like glucose, free fatty acids, and lactate as an energy source for its metabolism. Under normal physiologic conditions, 60% to 80% of energy-rich phosphate bonds are derived from oxidation of long-chain free fatty acids.' Therefore long-chain free fatty acids labeled with a radioisotope were proposed as indicators of cardiac metabolism in vivo. One of these radiolabeled free fatty acids was heptadecanoic acid (HDA) labeled with 123I in the omega position.
THE HEART uses a variety of substances like glucose, free fatty acids, and lactate as an energy source for its metabolism. Under normal physiologic conditions, 60% to 80% of energy-rich phosphate bonds are derived from oxidation of long-chain free fatty acids.' Therefore long-chain free fatty acids labeled with a radioisotope were proposed as indicators of cardiac metabolism in vivo. One of these radiolabeled free fatty acids was heptadecanoic acid (HDA) labeled with 123I in the omega position.
It was found that after administration of radiolabeled HDA, regional elimination of the radioactivity differed under various pathophysiologic conditions of the myocardium. In ischemic myocardium the elimination rate was found to be lower than that in comparable normal myocardium.A-"0 In some patients with a recently sustained infarction, a higher elimination rate was found. 1 " Patients with congestive cardiomyopathy showed a diffuse, inhomogeneous pattern of elimination.'2 The rate of elimination was also influenced by simultaneous administration of glucose and insulin. ' 1 These results suggested a potential use of radioiodinated HDA as metabolic tracer. Two hypotheses have been developed to explain the observed differences in elimination rates. Both hypotheses are related to cardiac metabolism of radioiodinated free fatty acids. After uptake in the myocyte, radioiodinated long-chain free fatty acids are degraded by /3-oxidation'4 in the mitochondria. Radioiodine is split off and leaves the cell.
In the first hypothesis the elimination rate is related to the /-oxidation rate of the radioiodinated fatty acids'5 in the mitochondria. In the second hypothesis the elimination rate is related to the diffusion rate of radioiodide from the myocardial mitochondria into the systemic circulation. 6 Because knowledge of the underlying mechanism is important for interpretation of scintigraphic data, this study was undertaken to ascertain which of the two hypotheses is correct. From normal canine myocardi-um serial biopsy specimens were taken after administration of '311-HDA. Distribution To determine the time course of radiolabeled components, count rates of biopsy specimens and fractions were also expressed as a percentage of the activity of the specimen with the highest count rate.
Both arterial and coronary sinus plasma activity was expressed as a percentage of the arterial plasma sample with the highest count rate in a dog. In all dogs the arterial sample with the highest count rate was obtained at the first minute after injection of 13 1-HDA.
For slight differences in sampling time of biopsy specimens and blood samples, interpolation was applied: a linear curve was fitted between two count rate data of adjacent sampling times.
The count rates on the exact sampling moment as mentioned above was calculated from this linear curve.
Scintigraphic study. In three dogs (Nos. 7, 8, and 10) a mobile gamma camera (Elseint Dymax MB) with a medium energy collimator was placed under the chest and scintigraphy was performed over 30 min. One minute frames were obtained in a matrix of 64 x 64 pixels. A region of interest was drawn over the myocardial area and the time-activity curve was displayed. Background correction for circulating free iodide in blood was performed as described previously21 between the fifth and thirtieth frame. In short, correction is based on subtraction of a constant background value from the myocardial count rates. The background activity in a myocardial region to be subtracted is determined by extrapolating a monoexponential curve through the myocardial time-activity curve and subtracting the calculated value at 60 min uniformly from the uncorrected curve. A monoexponential curve is fitted through the corrected count rates and half-time values are derived. This background procedure was validated by comparing the results of intravenous and intracoronary studies. 22 The corrected time-activity curve and the course of the radioactivity in biopsy specimens were compared.
Results
Before myocardial biopsy specimens were taken, Tables 1 to 3 show the radioactivity data in myocardial biopsy specimens and the distribution of the radioactivity originating from 113-HDA, free 131J, and the various radioiodinated lipids. Although anesthesia and blood pressure differed between dogs 1 to 6 and 7 to 10, no difference in the course of radioactivity was observed and all data are presented together. '311-HDA activity decreased from 19.7% in the first minute to 4.2% at 30 min. The relative contribution of radioiodide, radiolabeled phospholipids, and cholesterol-esters remained constant during the study. Activity of 311'-glycerides increased from 6.8% to 16%. Table 4 and figure 1 show the mean biopsy data expressed as a percentage of the specimen with the highest count rate. After injection of 113-HDA, total count rates of the biopsy specimens increased until the fifth minute; thereafter a decrease was observed. Halftime calculated by linear regression analysis of semilogarithmic plots from the fifth until the thirtieth minute was 36 min.
Of the analyzed metabolites, free 13'I contributed most to the curve of the total count rate, running parallel to this curve. The half-time of radioiodide calculated the same way as for total radioactivity was 25 min. As early as the first minute after administration, 131I-HDA activity had decreased to 13.5% of total radioactivity and diminished rapidly thereafter. Cholesterolesters remained a negligible fraction throughout the study, accounting for less than 1% of the radioactivity. After an initial increase during the first minutes, activ- figure 2 ). In the first minutes, the major component in plasma was '311-HDA, which then fell rapidly to low levels. The half-time of arterial 1311-HDA was 2.1 min. After 30 min almost 90% of the radioactivity in plasma was radioiodide. Figure 3 shows the averaged extraction fraction of '311-HDA on a sample-by-sample basis. The extraction fraction decreased significantly from 43 + 8% in the first minute to 30 ± 13% at the tenth minute (p < .01, Student's t test for unpaired data). At 20 min 1311-HDA activity in blood was too low for reliable calculation of the extraction fraction.
The ratio of free iodide activity in biopsy specimens vsbloodwas9.2 ± 5.4 at5 min and3.6 ± l.9at30 min after administration of '311-HDA.
Scintigraphy. In figure 4 the course of radioactivity in biopsy specimens and the corrected time-activity curve derived from the scintigram are shown. The half-time values of the scintigraphic curve were 20, 21, and 25 min in dogs 7, 8, and 10.
Discussion
Radiolabeled long-chain free fatty acids are used as noninvasive indicators of myocardial fatty acid metabolism. 23 Although palmitic acid labeled with an isotope of a natural element has been used successfully to quantify the pathophysiologic state of myocardial metabolism,24 25 high costs for production and detection figure 1 , total count rates of the biopsy specimens increased until the fifth minute; thereafter radioactivity decreased, with a half-time of 36 min. The increase in the first 5 min was caused by uptake of TABLE 4 '311-HDA from the arterial circulation, since in this period the major part of the blood radioactivity consists of 311-HDA ( figure 2 and table 5) .
Analysis of the components of the total activity curve (tables l to 4 and figure 1) shows that '3t1-HDA activity is less than 14% in the first minute and decreases during the study. Activity of radioiodinated glycerides and phospholipids remains constant after an initial increase during the first 5 min, and cholesterol esters remain a negligible fraction. The major part of the radioactivity consists of free radioiodide, and its curve runs parallel to that of the total radioactivity.
The Because lipid activity remains constant, the decrease of total myocardial activity is based on the decrease of free radioiodide. Thus it is concluded that in normal myocardium, washout of free radioiodide from the myocyte into the circulation determines the elimination rate as observed during a scintigraphic study.
As a result of release of iodide into the circulation, a high blood activity is built up, possibly interfering with washout of iodide from myocardium. Free iodide activity in biopsy specimens will not be influenced significantly by iodide in blood, as indicated by the iodide specimen-blood ratios of 9.2 and 3.6 at 5 and 30 min, respectively. Furthermore, Machulla et al. 30 found that after intravenous injection of '31I-Nal, activity of free iodide was maximally 10% of free iodide after injection of '311-HDA.
Relationship between biopsy specimens and scintigraphic results. In three dogs scintigraphy was performed in the same period biopsy specimens were taken. Background-corrected half-time values were slightly higher, as reported previously.26 Possibly the higher halftime values are related to the prolonged halothane anesthesia. 13 Because of differences in data collection, only a qualitative comparison can be made between biopsy and scintigraphic data. In these dogs the course of total radioactivity from the biopsy specimens is comparable with the time-activity curve.
Based on the results of this study, changes in the scintigraphic elimination rate might be explained by two factors: (1) Alterations in the diffusion rate of free radioiodide might have been caused by alterations in the porosity of mitochondrial and cellular membranes under ischemia or metbolic interventions. (2) In a previous study,3' the distribution of radioactivity in nor- 26. 33 The extraction fraction of 1311--HDA was calculated from the arterial-coronary sinus difference (figure 4). In the first minute the extraction fraction was 43%, decreasing to 30% in the tenth minute. These extrac- Tamre in rnin 
